Gauging the role and impact of drug interactions and repurposing in neurodegenerative disorders

• Egile Nagusiak: Dharmendra Kumar Khatri (Egilea), Amey Kadbhane (Egilea), Monica Patel (Egilea), Shweta Nene (Egilea), Srividya Atmakuri (Egilea), Saurabh Srivastava (Egilea), Shashi Bala Singh (Egilea)
• Formatua: Liburua
• Argitaratua: Elsevier, 2021-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Neurodegenerative diseases (ND) are of vast origin which are characterized by gradual progressive loss of neurons in the brain region. ND can be classified according to the clinical symptoms present (e.g. Cognitive decline, hyperkinetic, and hypokinetic movements disorder) or by the pathological pro...